Gene search


Sequence information


Select Gene Cds Cds_length GC_content Pep Pep_length
Phac2g01539 ATGCTAGGTGGGGGTATCAAAAGCAGCACCAGACTTAGACAATCATCATCATGCTCATGTCCATCCAGAATGGTTAAAATTTCACCTGAGCCTTCTTCTTCCTCTTTCTCTTCTACAGCACCTCTTAAAAGACACGATGTTTTCATCAGTTTTAGAGGTGAGGACACGCGCAACGGCTTCACAAGCCATCTCTATGCAGCCTTTCAGCACAACAAGATCCAAGCCTTCATAGATAACAGGCTTCACAAAGGGGAAGAGATCTCTCCCTCTATTTTTGAAGCCATCAAACACTCGAACCTATCTCTGGTTGTTCTCTCCAAGTACTATGCTTCCTCCACCTGGTGCTTGCGTGAACTTGCCAAAATACTTGAACTCAAGAAACGTGGAGGACACACTGTGATACCTGTTTTCTATAAGATTGATCCTTCCCATGTACGGAAGCAGACTGGAACTTACGGGATGGCGTTTCAAAAATATCAAAGAGATGTTAAACAAAACATGGCCATGTTGCAGAAATGGAAAGCTGCTCTCACTGAAGTGGCCGATATAGTTGGGTGGGAATTAAAGAATTTTAGGACGGAGTATGAACTCATTGGGGAAATTGTCAAAGACGTTATGCAAAAACTAAACCATTTGTATCCCACTGAAGTAAAAGAAACACTTGTTGGAATTGATCAAAATCTTGCTCCTATTGAATCATTATTAAGAATAAGGTCAAAAGAAGTTCGCATAATCGGAATTTGGGGTATGGGTGGATTAGGTAAGACAACCATTGCGGGCGCTTTATTTGCCAAATTATCATCTCAATTTGAAGCTAGTTGCTTCTTGGCAAATGTGAAGGAAGAACATGAAAAGCAAGGACTTGATTATTTACGCAATAAACTTCTTTCTGGGATATTAGAAGATGTGAATCCCCATATAAGCACTTCCAAAGTGAGAACTACGTTTGTTATGAAGAGGCTTAGACAAAAAAAGGTTTTGATAGTGCTTGATGATGTGGACGATCCAAAGAAACTGGAATATCTTGCTGCACAACATGATTGCTTGGGATCTGGTAGTAGAGTCATTGTCACTACAAGAGACAAGCATGTCCTTAGCAGAGGGGTAGATGCAATCTATGAGGTTAAGGGATTGTCCCTTCATCATGCTGTTAGGCTTTTTAGTTTAAATTCCTTCGGCAAAACTTATCCTGAAAGGGGCTTTGAAATGCTATCTAAACAGGCGGTTGATCATGCAAATGGAAATCCATTGGCTTTAAAAGTTTTAGGTTCAGTTCTCCATTCCAGAAATGAGCAGCAATGGGACAATGCTCTGAGAAAATTCAAGAAGGTTCCTAATGCAGAAATTCAGAATGTCTTGAGATGGAGTTATGATGGATTAGATTATGAACAAAAAAACATGTTCCTGGACATTGCATGCTTTTTCCGAGGAGAAAATAAAGAAAATGTTATAAGGCTACTCGATATTTGTGGTTTCTATGCATATATTGGTATAAAAGTGCTTCTAGAAAAAGGTCTTATAACATTTTCTGATGAAGGTAACGTGTGTATGCATGAATTGATACAAGAAATGGGTTGGGAAATTGTTCATCAGGAATCTATCAACGATCCTGGAAGGCGTAGCCGATTGTGGGATCTTAAAGAAGTCTATGATGTATTGAAAAATAACAGGGGAACTGAAGCAGTTGAAGGCATAATCTTAGATGTGTCTCAAGTAAGAGTCCTGCTACTGAACTATGAGACCTTCTCAAGGATGGTGAATATGAGATTTCTCAAATTCTATATGGGGAGGGATAGGAAATGCAATTTGCACCTTCCTTCAGGTCTCGAATCCTTGCCTAATAAATTAATGTACCTACAATGGGATGGATACCCTTCTAAGTCTCTGCCATCAACTTTTTGTCCTGACAACCTTGTTGTGCTTTCCATGATGGAAAGCCACGTTGAGAAACTTTGGGATGGAATCAAGAGTCTTCCAAGCTTGAAAGAGCTCAACCTCCGTGCCAGCAAAAATTTAACTAAGCTCCCAGATTTATCACAGGCACCAAATCTTGAAACTATAGATGTTTCCTATTGCACTAGTCTGCTTCATATTCCCTTATCTATCCAACATGTCAAGAGGCTTCTTCTGTTTAACTTGGAATCCTGCAAGAGTCTCAAGAGTCATCCAAGAACCATTCACTTATCTTCTCTTGAAATGTTCATTCTGAGACGCTGTTCTAGTCTTGATGAGTTTCCATTGACTTCAGAGAACATGACACGCCTAGACTTGAAAGAAACAGCAATAGCAGATTTCCCAGAGTCTGTTTGGCAGCATCTGAACAAGCTTGTTTACTTGAATCTGGAATCCTGCAACAAACTCAAGAGTCTTACAAGCAAGATTCACTTAAAATCTCTTCAAATACTCAATATGAGAGATTGTTCAATTCTTGAAGAGTTTTCTGTGACTTCGGAGAACATGGAATACTTGAATTTGAGAGGCACATCAATAAAAGAATTGCCAACATCAGTTTGGCGCAATAACAAGCTTTATACTTTGGTTCTTCATTCCTGTAAAAAACTGGTGAATTTTCCTGAAAGACCAAAACTTGAGGATTTACCTCTCGTATCCTCCTCTGAAAGGCCAAATATGGATGAACTATGGACTTTGTCATCCTTAGCAGATTTATCACTAAAAGGAAGCACTATTGAAAATTTACCTGCAAGCATCAAAGATCTTCCTAGTCTAAAAAAACTTACCTTGACTGAGTGCAAGAAGCTGCGGTCCTTACCAAGCCTTCCACCATCCTTAGAAGACCTATCCTTAGATGAAAGTAATATTGTGTGCTTACCTGTAAGTATCAAAGATCTTTCTCATTTGAGAAAACTTGCCCTAATTAACCACAAGAAGTTTTTGTCTCCACAGGATCATCCACCATCTTTGAATGAAATTAAAGTCGATCCACATCTTGTGAGCATGAAAGGTCTTTCTCAACTACAGAAGTTTCCTCAGGTTAAGTGGAAAAGCTTTCATTCTCTACCAGAGCTTCCACCATTCTTGGAAGAATTTTCCCTAAGTGAAAGCAATATTAAGTGCATACCTGAAAGCATTAAATATCTTTCACATCTGAGGAAACTAGCCTTAACAAAGTGCACGAGGCTTCAGTGTTTACCAGAGCTTCCGCCAACTTTGGAAGATTTGTTTGTAAGTGGATGTGACATTGAAAGCTTGCCAATAAGCATCAAATATCTAGTTCATCTGCGAAAGATCACCTTAATTGAGTGCAAGAAGCTCAAGGCTTTACCAGAGCTCCCACAATGCTTGCAATCATTGTGTGTAGCTGACTGCAGATCACTCACGATTGTTCGAAGTACAAAGAATATCTTAATAGAAGATAGATATGCATTCTATTGTAATTGCATAAACTTAGACCAAAAGTCGCGCAACAATATCATTGCAGATTCGCCCTTTGAGGCAGCATATACTTCTTTGAAAGAAAGAACACCTCTTGGTCCTCTTATTTCTATTTGTTTGCCAGGAACTGAAATCCCAGACTGGTTCAGCTACCAATCAACAAATTCTTCACTGGACATGGAAATTCCTCTAGAGTGGTTCGTTGACTCGGTGTTCTTAGGTTTTGCTCTGTGCCTTGTAATTGGTGGTTTCCAACAGAACAGTTATAAAGGGTATGATCCAGATATCAATTGTTATCACTTTGTAAAATCTGCCTCCTACTCTGGCCCCAGTGTTCCCTTTCTTGGCCATTGCACAACTGTAATGCAGGTGCCAAGAGGTTTTAATTCAGATCATATATTTATATGCTACTATCCCACTTTTAATGCCTCTATACTGCAAGACTTCAAGGATTTAAGCTTGTACTATGATGCCAATAACCCAAGACTGAGAGTAATCTTTAAATTTAAGGGTCCATCTCAACGGTTGGACATTGTTAAGAAGTGCGGGGTCAGACCTCTTTTGATTGCAAATACTGAAAAGCTTCACGTAGAAAGTGAACAGCAACCTGAATAG 4008 0.3932 MLGGGIKSSTRLRQSSSCSCPSRMVKISPEPSSSSFSSTAPLKRHDVFISFRGEDTRNGFTSHLYAAFQHNKIQAFIDNRLHKGEEISPSIFEAIKHSNLSLVVLSKYYASSTWCLRELAKILELKKRGGHTVIPVFYKIDPSHVRKQTGTYGMAFQKYQRDVKQNMAMLQKWKAALTEVADIVGWELKNFRTEYELIGEIVKDVMQKLNHLYPTEVKETLVGIDQNLAPIESLLRIRSKEVRIIGIWGMGGLGKTTIAGALFAKLSSQFEASCFLANVKEEHEKQGLDYLRNKLLSGILEDVNPHISTSKVRTTFVMKRLRQKKVLIVLDDVDDPKKLEYLAAQHDCLGSGSRVIVTTRDKHVLSRGVDAIYEVKGLSLHHAVRLFSLNSFGKTYPERGFEMLSKQAVDHANGNPLALKVLGSVLHSRNEQQWDNALRKFKKVPNAEIQNVLRWSYDGLDYEQKNMFLDIACFFRGENKENVIRLLDICGFYAYIGIKVLLEKGLITFSDEGNVCMHELIQEMGWEIVHQESINDPGRRSRLWDLKEVYDVLKNNRGTEAVEGIILDVSQVRVLLLNYETFSRMVNMRFLKFYMGRDRKCNLHLPSGLESLPNKLMYLQWDGYPSKSLPSTFCPDNLVVLSMMESHVEKLWDGIKSLPSLKELNLRASKNLTKLPDLSQAPNLETIDVSYCTSLLHIPLSIQHVKRLLLFNLESCKSLKSHPRTIHLSSLEMFILRRCSSLDEFPLTSENMTRLDLKETAIADFPESVWQHLNKLVYLNLESCNKLKSLTSKIHLKSLQILNMRDCSILEEFSVTSENMEYLNLRGTSIKELPTSVWRNNKLYTLVLHSCKKLVNFPERPKLEDLPLVSSSERPNMDELWTLSSLADLSLKGSTIENLPASIKDLPSLKKLTLTECKKLRSLPSLPPSLEDLSLDESNIVCLPVSIKDLSHLRKLALINHKKFLSPQDHPPSLNEIKVDPHLVSMKGLSQLQKFPQVKWKSFHSLPELPPFLEEFSLSESNIKCIPESIKYLSHLRKLALTKCTRLQCLPELPPTLEDLFVSGCDIESLPISIKYLVHLRKITLIECKKLKALPELPQCLQSLCVADCRSLTIVRSTKNILIEDRYAFYCNCINLDQKSRNNIIADSPFEAAYTSLKERTPLGPLISICLPGTEIPDWFSYQSTNSSLDMEIPLEWFVDSVFLGFALCLVIGGFQQNSYKGYDPDINCYHFVKSASYSGPSVPFLGHCTTVMQVPRGFNSDHIFICYYPTFNASILQDFKDLSLYYDANNPRLRVIFKFKGPSQRLDIVKKCGVRPLLIANTEKLHVESEQQPE* 1336
       

Annotation information


Select Seq ID Length Analysis Description Start End IPR GO
Phac2g01539 1335 Gene3D Ribonuclease Inhibitor 930 1122 IPR032675 -
Phac2g01539 1335 Gene3D Ribonuclease Inhibitor 545 750 IPR032675 -
Phac2g01539 1335 Gene3D Ribonuclease Inhibitor 751 929 IPR032675 -
Phac2g01539 1335 ProSiteProfiles TIR domain profile. 43 209 IPR000157 GO:0007165
Phac2g01539 1335 Pfam NB-ARC domain 232 447 IPR002182 GO:0043531
Phac2g01539 1335 Pfam C-JID domain 1171 1316 IPR045344 -
Phac2g01539 1335 SUPERFAMILY Toll/Interleukin receptor TIR domain 40 186 IPR035897 -
Phac2g01539 1335 SUPERFAMILY P-loop containing nucleoside triphosphate hydrolases 204 471 IPR027417 -
Phac2g01539 1335 Gene3D - 210 371 IPR027417 -
Phac2g01539 1335 FunFam Disease resistance protein RPS4 559 750 - -
Phac2g01539 1335 SUPERFAMILY L domain-like 517 863 - -
Phac2g01539 1335 MobiDBLite consensus disorder prediction 1 39 - -
Phac2g01539 1335 PANTHER LEUCINE-RICH REPEAT-CONTAINING PROTEIN 45 787 IPR044974 GO:0006952
Phac2g01539 1335 Pfam TIR domain 45 224 IPR000157 GO:0007165
Phac2g01539 1335 Pfam Leucine Rich Repeat 637 656 IPR011713 -
Phac2g01539 1335 Gene3D - 378 461 IPR042197 -
Phac2g01539 1335 Gene3D - 42 209 IPR035897 -
Phac2g01539 1335 PRINTS Disease resistance protein signature 244 259 - -
Phac2g01539 1335 PRINTS Disease resistance protein signature 320 334 - -
Phac2g01539 1335 PRINTS Disease resistance protein signature 412 426 - -
Phac2g01539 1335 PRINTS Disease resistance protein signature 904 920 - -
Phac2g01539 1335 SUPERFAMILY L domain-like 880 1159 - -
Phac2g01539 1335 FunFam Disease resistance protein (TIR-NBS-LRR class) 42 211 - -
Phac2g01539 1335 SMART till_3 44 183 IPR000157 GO:0007165
Phac2g01539 1335 MobiDBLite consensus disorder prediction 8 39 - -
       

Duplication type information


Select Gene Chromosome Start End Duplicated_type
Phac2g01539 Phac-Chr2 14576874 14581954 Tandem
       

Functional genes information


Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Phac2g01539 23 837 WRKY Transcription Factor Family AT4G12020 36.823 1.19e-130 441
       

Pathway information


Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Phac2g01539 - - gmx:100797269 2206.41